| PD | Parkinson’s disease |
| iPD | idiopathic Parkinson’s disease |
| AD | Alzheimer’s disease |
| CNS | Central nervous system |
| REM | Rapid eye movement |
| NREM | Non-rapid eye movement |
| RBD | Rapid eye movement sleep behavior disorder |
| iRBD | idiopathic Rapid eye movement sleep behavior disorder |
| EDS | Excessive daytime sleeping |
| RLS | Restless leg syndrome |
| OSA | Obstructive sleep apnea |
| SRBD | Sleep-related breathing disorder |
| CRSWD | Circadian rhythm sleep–wake disorder |
| DSWPD | Delayed sleep–wake phase disorder |
| α-SYN | Alpha-synuclein |
| SCNA | Alpha-synuclein |
| PARK2 | Parkin 2 |
| LRRK2 | Leucine-rich repeat kinase 2 |
| PINK | PTEN-induced putative kinase |
| PRKN | Parkin RBR E3 ubiquitin-protein ligase |
| GBA | Glucocerebrosidase genes |
| ATP13A2 | ATPase type 13A2 |
| ICSD | International Classification of sleep disorders |
| CSF | Cerebrospinal fluid |
| LBD | Lewy body dementia |
| SNPc | Substantia nigra pars compacta |
| SN | Substantia nigra |
| VTA | Ventral tegmental area |
| PVN | Paraventricular nucleus |
| MPN | Medial preoptic nucleus |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| DA | Dopamine |
| GABA | Gamma-aminobutyric acid |
| IL-1β | Interleukin-1β |
| TNF-α | Tumour necrosis factor- α |
| ESS | Epworth sleepiness scale |
| DaTSCAN | Dopamine transporter scan |
| CLOCK | Circadian locomotor output cycles kaput |
| HCRT2-SAP | Hypocretin-2-sap |
| CPAP | Continuous positive airway pressure |
| EMG | Electromyographic |
| MoCA | Montreal cognitive assessments |
| MMSE | Mini-mental State Examination |
| D2R | Dopamine 2 receptor |
| PLMS | Periodic leg movements in sleeping |
| ALS | Amyotrophic lateral sclerosis |
| ARAS | Ascending reticular activating system |
| SCN | Suprachiasmatic nucleus |
| PER3 | Period circadian regulator 3 |
| CRY1 | Cryptochrome |
| Nr1d1 | Nuclear receptor subfamily 1 group D member 1 |
| Nr1d2 | Nuclear receptor subfamily 1 group D member 2 |
| PDSS | Parkinson’s disease sleep scale |
| SCOPA | Scales for outcomes in PD sleep |
| PSQI | Pittsburgh sleep quality index |
| RBDSQ | RBD screening questionnaire |
| RBD-I | Innsbruck RBD inventory |
| RBDQ-HK | Hong Kong RBD questionnaire |
| RBD-IQ | RBD-single question screen |
| MSGBs | Minor salivary gland biopsies |
| CSHQ | Cleveland sleep habits questionnaire |
| MRPI | Magnetic resonance parkinsonism index |
| MRI | Magnetic resonance imaging |
| DTI | Diffusion tensor imaging |
| fMRI | Functional magnetic resonance imaging |
| FA | Fractional anisotropy |
| TMS | Transcranial magnetic stimulation |
| DAT-SPECT | Dopamine transporter single-photon emission computed tomography |
| BLT | Bright light therapy |
| CBT | Cognitive behavioral therapy |
| PBM | Photobiomodulation |
| tDCS | Transcranial direct current stimulation |
| LCIG | Levodopa/carbidopa intestinal gel |
| LCE | Levodopa/carbidopa/entacapone |